http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S55139370-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_067cda10aaf6d4a5ca8180abe5a545c6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-10
filingDate 1979-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_815ac34e9e4115d0bcbf23a86f1b8c3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f01cfa7289bb968c35afd2dc09012ca1
publicationDate 1980-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S55139370-A
titleOfInvention Preparation of 1,4-di-substituted piperazine
abstract PURPOSE: To prepare the title compound useful as an antitussive, etc., in high yield, with a simple and economical process, by reacting 1-(2-phenyl-2-alkoxyethyl)-4- (halomethyl)-piperazine, etc. with a propiophenone derivative. n CONSTITUTION: The compound III is prepared by reacting a compound I (R is H, or alkyl; X ia halogen or OH) with a compound II (R 1 is H, halogen, alkyl or alkoxy), pref. in the presence of an organic solvent (e.g. alcohol, ether, aromatic hydrocarbon, etc.). The use of a reaction catalyst improves the yield of the compound III. The catalyst is either a basic catalyst (e.g. triethylamine) or a dehydration catalyst (e.g. dicyclohexylcarbodimide) depending upon whether the X of formula I is halogen or OH. The compound I is a novel compound, and can be prepared by reducing the reaction product of a compound IV and a halogenocarbonic acid alkyl ester. n COPYRIGHT: (C)1980,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03227575-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0558271-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05234473-A
priorityDate 1979-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5422379-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226455998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602

Total number of triples: 31.